One Way Holdings LLC decreased its position in shares of Synopsys, Inc. (NASDAQ:SNPS – Free Report) by 98.8% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 820 shares of the semiconductor company’s stock after selling 65,467 shares during the period. One Way Holdings LLC’s holdings in Synopsys were worth $357,000 as of its most recent filing with the Securities and Exchange Commission.
Several other hedge funds also recently modified their holdings of the company. BlackRock Inc. bought a new position in shares of Synopsys in the second quarter valued at approximately $7,228,099,000. Mitsubishi UFJ Asset Management Co. Ltd. bought a new stake in Synopsys during the 2nd quarter worth approximately $747,400,000. Bank of New York Mellon Corp bought a new stake in Synopsys during the 2nd quarter worth approximately $692,074,000. Bank of America Corp DE acquired a new stake in Synopsys during the 2nd quarter valued at $539,986,000. Finally, Legal & General Group Plc acquired a new stake in Synopsys during the 2nd quarter valued at $491,923,000. Institutional investors and hedge funds own 85.47% of the company’s stock.
Wall Street Analysts Forecast Growth
Several equities analysts have issued reports on the company. Rosenblatt Securities lifted their price objective on Synopsys from $575.00 to $620.00 and gave the company a “buy” rating in a research report on Thursday, October 1st. Weiss Ratings cut Synopsys from a “hold (c)” rating to a “hold (c-)” rating in a report on Friday, September 11th. Wells Fargo & Company increased their target price on Synopsys from $475.00 to $540.00 and gave the stock an “overweight” rating in a report on Thursday, October 1st. Robert W. Baird upgraded Synopsys from a “neutral” rating to an “outperform” rating and raised their target price for the company from $558.00 to $560.00 in a research note on Thursday, August 27th. Finally, Roth Capital raised Synopsys to a “buy” rating in a report on Friday, September 25th. One equities research analyst has rated the stock with a Strong Buy rating, twenty-two have given a Buy rating and three have given a Hold rating to the company’s stock. Based on data from MarketBeat, Synopsys currently has an average rating of “Moderate Buy” and a consensus target price of $575.00.
Insider Buying and Selling at Synopsys
In other news, insider Janet Lee sold 1,144 shares of the firm’s stock in a transaction dated Tuesday, October 6th. The shares were sold at an average price of $502.52, for a total value of $574,882.88. Following the transaction, the insider owned 16,534 shares of the company’s stock, valued at approximately $8,308,665.68. This trade represents a 6.47% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, CEO Sassine Ghazi sold 14,604 shares of Synopsys stock in a transaction that occurred on Tuesday, September 15th. The stock was sold at an average price of $374.88, for a total transaction of $5,474,747.52. Following the sale, the chief executive officer owned 76,865 shares of the company’s stock, valued at approximately $28,815,151.20. This represents a 15.97% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 117,163 shares of company stock worth $51,366,457 over the last quarter. Company insiders own 0.56% of the company’s stock.
Synopsys Trading Down 0.3%
Shares of SNPS opened at $466.08 on Tuesday. The company has a quick ratio of 1.24, a current ratio of 1.34 and a debt-to-equity ratio of 0.29. Synopsys, Inc. has a 12-month low of $362.55 and a 12-month high of $539.48. The firm has a market capitalization of $89.32 billion, a PE ratio of 48.97, a price-to-earnings-growth ratio of 1.96 and a beta of 1.21. The stock’s fifty day simple moving average is $438.84 and its 200-day simple moving average is $443.39.
Synopsys (NASDAQ:SNPS – Get Free Report) last announced its quarterly earnings data on Wednesday, August 26th. The semiconductor company reported $3.91 EPS for the quarter, topping analysts’ consensus estimates of $3.67 by $0.24. The firm had revenue of $2.48 billion during the quarter, compared to analyst estimates of $2.44 billion. Synopsys had a return on equity of 6.24% and a net margin of 11.43%. The company’s revenue was up 42.4% on a year-over-year basis. During the same period last year, the company earned $3.39 earnings per share. Synopsys has set its Q4 2026 guidance at 4.100-4.160 EPS and its FY 2026 guidance at 15.040-15.100 EPS. As a group, research analysts predict that Synopsys, Inc. will post 11.01 earnings per share for the current year.
Synopsys announced that its Board of Directors has approved a stock repurchase plan on Monday, October 5th that allows the company to repurchase $1 billion in outstanding shares. This buyback authorization allows the semiconductor company to purchase up to 1.1% of its stock through open market purchases. Stock buyback plans are generally an indication that the company’s board believes its stock is undervalued.
Synopsys Profile
Synopsys, Inc is an electronic design automation (EDA) and semiconductor intellectual property company serving the global semiconductor and electronics industries. Its software helps engineers design, verify, test and manufacture advanced integrated circuits and electronic systems.
The company’s products and services support digital and analog design, functional verification, design-for-test, manufacturing and semiconductor engineering workflows. Synopsys also provides reusable semiconductor IP, including processor cores, interface technologies, security solutions and other components used in system-on-chip designs.
In addition to its semiconductor design offerings, Synopsys provides software development and application security tools intended to help organizations identify and manage vulnerabilities and risks across the software development lifecycle.
See Also
- Five stocks we like better than Synopsys
- AbbVie’s Humira Era Is Fading, But Its New Growth Engines Face Another Test
- GLP-1 Focus or Broader Peptide Exposure: Which ETF Has the Edge?
- Mortgage Rates Froze U.S. Housing, But These 3 Overseas Markets Still Pay Double Digits
- Big Tech Is Spending Billions on AIāThese 5 Stocks Are Getting Paid
Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPS – Free Report).
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.
